^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HER-2 pulsed DC1

    i
    Associations
    News

    Trials

    Company:
    H. Lee Moffitt Cancer Center and Research Institute, ImmunoRestoration, University of Pennsylvania
    Drug class:
    Immunostimulant, Dendritic cell activator
    Related drugs:
    Associations
    News

    Trials

    Apply
    Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab (NATASHA) (NCT05325632)
    Phase 2
    H. Lee Moffitt Cancer Center and Research Insti...
    Recruiting
    Last update posted :
    12/24/2024
    Initiation :
    10/28/2021
    Primary completion :
    01/31/2025
    Completion :
    01/31/2025
    HER-2
    |
    Herceptin (trastuzumab) • Perjeta (pertuzumab) • albumin-bound paclitaxel • HER-2 pulsed DC1